Nutex Health (NUTX) Net Margin (2010 - 2026)

Nutex Health has disclosed Net Margin across 15 years of filings, most recently posting 28.99% for Q1 2026.

• Net Margin for Q1 2026 came in at 28.99%, up 2193.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 21.86% (up 410.0% YoY), and the FY2025 annual result was 20.61%, up 973.0% from the prior year.
• Net Margin came in at 28.99% for Q1 2026 at Nutex Health, up from 10.95% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 38.84% in Q4 2024 to a low of 1488.0% in Q3 2022.
• The 5-year median for Net Margin is 3.96% (2024), against an average of 84.56%.
• Across the five-year window, Net Margin slumped 153360 bps in 2022 and soared 148079 bps in 2023, its largest moves.
• Nutex Health's Net Margin stood at 18.48% in 2022, then plunged by 315 bps to 39.78% in 2023, then surged by 198 bps to 38.84% in 2024, then plunged by 72 bps to 10.95% in 2025, then surged by 165 bps to 28.99% in 2026.
• The last three Net Margin figures came in at 28.99% (Q1 2026), 10.95% (Q4 2025), and 36.15% (Q3 2025), per Business Quant data.